The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes

Ronald Klein, Kayla Horak, Kristine E. Lee, Lorraine Danforth, Karen J. Cruickshanks, Michael Y. Tsai, Ronald E. Gangnon, Barbara E.K. Klein

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)e117-e119
JournalDiabetes care
Volume40
Issue number9
DOIs
StatePublished - Sep 1 2017

Bibliographical note

Funding Information:
Acknowledgments. Ryan Schryver and Will Kelly of the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, assisted with the technical editing and preparation of the manuscript. They received no additional compensation beyond their normal wages as employees of the University of Wisconsin–Madison for their assistance. Funding. This research was supported by the National Institutes of Health National Eye Institute grant EY016379 (R.K. and B.E.K.K.) and an unrestricted grant from Research to Prevent Blindness, New York, NY.

Cite this